Browsing by Author "Bardien, Soraya"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Patient-Control Association Study of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene in South African Parkinson's Disease Patients
    (National Institute of Health, 2013) Bardien, Soraya; Blanckenberg, Janine; van der Merwe, Lize; Farrer, Matthew J.; Ross, Owen A.
    The leucine-rich repeat kinase 2 (LRRK2) gene is of interest to Parkinson's disease (PD) as it has been implicated in both familial and sporadic forms of the disorder.1 PD-susceptibility alleles in LRRK2 appear to be ethnic-specific with G2385R,2 R1628P3 and A419V4 identified in Asian populations, whereas M1646T is found in Caucasians.4 A haplotype protecting against development of PD is present in Chinese (N551K-R1398H)5 and Caucasians (N551K-R1398H-K1423K).4 Further studies are necessary to investigate the contribution of LRRK2 to PD-susceptibility in various populations worldwide.
  • Thumbnail Image
    Item
    Rutin as a potent antioxidant: implications for neurodegenerative disorders
    (Hindawi Publishing Corporation, 2018) Enogieru, Adaze Bijou; Haylett, William; Hiss, Donavon Charles; Bardien, Soraya; Ekpo, Okobi Eko
    A wide range of neurodegenerative diseases (NDs), including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and prion diseases, share common mechanisms such as neuronal loss, apoptosis, mitochondrial dysfunction, oxidative stress, and inflammation. Intervention strategies using plant-derived bioactive compounds have been offered as a form of treatment for these debilitating conditions, as there are currently no remedies to prevent, reverse, or halt the progression of neuronal loss. Rutin, a glycoside of the flavonoid quercetin, is found in many plants and fruits, especially buckwheat, apricots, cherries, grapes, grapefruit, plums, and oranges. Pharmacological studies have reported the beneficial effects of rutin in many disease conditions, and its therapeutic potential in several models of NDs has created considerable excitement. Here, we have summarized the current knowledge on the neuroprotective mechanisms of rutin in various experimental models of NDs. The mechanisms of action reviewed in this article include reduction of proinflammatory cytokines, improved antioxidant enzyme activities, activation of the mitogen-activated protein kinase cascade, downregulation of mRNA expression of PD-linked and proapoptotic genes, upregulation of the ion transport and antiapoptotic genes, and restoration of the activities of mitochondrial complex enzymes. Taken together, these findings suggest that rutin may be a promising neuroprotective compound for the treatment of NDs.